Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

STO/BIOA.B stock hub

STO/BIOA.B has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

STO/BIOA.Bis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

28.2B

Nasdaq Stockholm

Market data

Live price

Current market quote for this ticker.

Current price

STO/BIOA.B

In the news

Latest news · STO/BIOA.B

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 14.9P50 22.5P75 31.5

Trailing P/E27.6

P25 17.3P50 29.9P75 44.5

ROE71.4

P25 -86.1P50 -28.3P75 4.6

ROIC57.8

P25 -52.4P50 -16.9P75 5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All STO/BIOA.B market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

202

Groups with data

Currency

SEK

Showing 202 of 202 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Sweden
Country code	SE
Employees	129
Employees Change	22%
Employees Change Percent	20.56
Enterprise value	SEK 26B
Exchange	Nasdaq Stockholm
Financial currency	SEK
First seen	2026-05-10
Industry	Biotechnology
Isin	SE0010323311
Last refreshed	2026-05-10
Market cap	SEK 28.2B
Price	SEK 318
Price currency	SEK
Rev Per Employee	15,496,984.5x
Sector	Healthcare
Sic	2836
Symbol	sto/BIOA.B
Website	https://www.bioarctic.se

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.63%
EV Earnings	25.46x
EV/EBIT	19.03x
EV/EBITDA	18.82x
EV/FCF	18.32x
EV/Sales	13.02x
FCF yield	5.04%
P/B ratio	14.32x
P/E ratio	27.57x
P/S ratio	14.09x
PE Ratio3 Y	55.74x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	68.44%
FCF margin	71.07%
Gross margin	97.04%
Gross Profit	SEK 1.9B
Gross Profit Growth	742.09%
Gross Profit Growth Q	89.04%
Gross Profit Growth3 Y	132.12%
Gross Profit Growth5 Y	164.57%
Net Income	SEK 1B
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Pretax Margin	62.81%
Profit Margin	51.14%
Profit Per Employee	SEK 7.9M
Profitable Years	1
ROA	46.39
Roa5y	8.01
ROCE	66.6
ROE	71.44
Roe5y	12.53
ROIC	57.77

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	74.57%
Cagr3y	3.7%
Cagr5y	30.73%
EPS Growth Quarters	1
EPS Growth Years	1
Revenue Growth	676.8x
Revenue Growth Q	81.79x
Revenue Growth Quarters	5x
Revenue Growth Years	1x
Revenue Growth3 Y	105.78x
Revenue Growth5 Y	98.29x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	SEK 1.08
Assets	SEK 2.6B
Cash	SEK 2.2B
Current Assets	SEK 2.5B
Current Liabilities	SEK 520.8M
Debt	SEK 44.1M
Debt EBITDA	SEK 0.03
Debt Equity	SEK 0.02
Debt FCF	SEK 0.03
Equity	SEK 2B
Interest Coverage	675.3
Liabilities	SEK 608.1M
Long Term Assets	SEK 88.3M
Long Term Liabilities	SEK 87.4M
Net Cash	SEK 2.1B
Net Cash By Market Cap	SEK 7.62
Net Cash Growth	196.18%
Net Debt Equity	SEK -1.09
Net Debt FCF	SEK -1.51
Tangible Book Value	SEK 2B
Tangible Book Value Per Share	SEK 22.19
WACC	-0.02

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.78
Net Working Capital	SEK -208.5M
Quick ratio	4.76
Working Capital	SEK 2B
Working Capital Turnover	SEK 1.43

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.23%
Dividend Growth	0%
Dividend Growth Years	1%
Dividend per share	SEK 2
Dividend Years	1
Dividend Yield	0.63%
Ex Div Date	2026-05-29
Last Dividend	SEK 2
Payout Ratio	17.36%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	74.51%
200-day SMA	297.4
3Y total return	11.52%
50-day SMA	317.5
50-day SMA vs 200-day SMA	50over200
5Y total return	281.73%
All Time High	392
All Time High Change	-18.98%
All Time High Date	2023-06-12
All Time Low	20.4
All Time Low Change	1,456.86%
All Time Low Date	2018-03-27
ATR	13.35
Beta	-0.78
Beta1y	0.84
Beta2y	0.41
Ch YTD	2.19
High	326
High52	364.4
High52 Date	2026-02-18
High52ch	-12.84%
Low	313.2
Low52	165.5
Low52 Date	2025-05-12
Low52ch	91.9%
Ma50ch	0.03%
Price vs 200-day SMA	6.81%
RSI	46.84
RSI Monthly	61.93
RSI Weekly	54.56
Sharpe ratio	1.15x
Sortino ratio	1.98
Total Return	0.4%
Tr YTD	2.19
Tr1m	1.15%
Tr1w	-3.23%
Tr3m	3.52%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	SEK 1.4B
Operating margin	68.44

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	54,395,820%
Net Borrowing	890,000
Shares Insiders	32.2%
Shares Institutions	43.69%
Shares Out	88,719,485
Shares Qo Q	0.06%
Shares Yo Y	0.23%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	SEK 1.4B
Average Volume	241,343x
Bv Per Share	22.19
CAPEX	SEK -10.2M
Ch1m	1.15
Ch1w	-3.23
Ch1y	74.51
Ch3m	3.52
Ch3y	11.52
Ch5y	281.7
Ch6m	20.49
Change	-4.34%
Change From Open	-1.98
Close	332
Days Gap	-2.41
Depreciation Amortization	15,205,000
Dollar Volume	89,590,196
Earnings Date	2026-04-21
EBIT	SEK 1.4B
EPS	SEK 11.52
F Score	6
FCF	SEK 1.4B
FCF EV Yield	5.46x
FCF Per Share	SEK 16.01
Financing CF	26,904,000
Fiscal Year End	December
Founded	2,000
Graham Number	75.84209
Graham Upside	-76.12
Income Tax	SEK 233.3M
Investing CF	-894,647,000
Is Primary Listing	1
Last Earnings Date	2026-04-21
Last Report Date	2025-12-31
Ma150	311.2
Ma150ch	2.07%
Ma20	325.5
Ma20ch	-2.41%
Net CF	527,503,000
Next Earnings Date	2026-05-15
Open	324
P FCF Ratio	19.83
P OCF Ratio	19.69
Payment Date	2026-06-04
Position In Range	34.38
Ppne	82,984,000
Price Date	2026-05-08
Ptbv Ratio	14.32
Relative Volume	1.17x
Revenue	1,999,111,000x
SBC By Revenue	1.2x
Share Based Comp	24,044,000
Tax By Revenue	11.67x
Tax Rate	18.58%
Tr6m	20.49%
Volume	282,085
Z Score	24.72

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

STO/BIOA.B dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.6%

$2.00 annual per share

Payout ratio

+17.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

1 consecutive years of growth

Total shareholder yield

+0.4%

Next ex-dividend date: 2026-05-29

Performance

STO/BIOA.B stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns STO/BIOA.B?

Insider, institutional, and short-interest positioning.

Institutional ownership

+43.7%

Share of float held by funds and institutions

Insider ownership

+32.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.2%

Negative means the company is buying back shares.

Technical

STO/BIOA.B momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.8

Neutral momentum band

Price vs 200-day MA

+6.8%

50/200-day relationship not available

Beta (5Y)

-0.78

Less volatile than the market

Sharpe ratio

1.15

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About STO/BIOA.B

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sto/BIOA.B stock rating?

sto/BIOA.B is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sto/BIOA.B analysis?

The full report lives at /stocks/sto/BIOA.B/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sto/BIOA.B?

The latest report frames sto/BIOA.B around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sto/BIOA.B page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.